Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention.
about
Identification of unique gene expression profile in children with regressive autism spectrum disorder (ASD) and ileocolitisHyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trialImpaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbancesComplementary and alternative medicine treatments for children with autism spectrum disordersThe genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disordersA genetic variant that disrupts MET transcription is associated with autismClinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.From genes to environment: using integrative genomics to build a "systems-level" understanding of autism spectrum disordersDecreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal DiseaseInvolvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expressionImmunologic and neurodevelopmental susceptibilities of autismGene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesisDifferential monocyte responses to TLR ligands in children with autism spectrum disorders.Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder.Association of maternal exposure to childhood abuse with elevated risk for autism in offspring.Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathwayElevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders.Autism spectrum disorders: concurrent clinical disorders.Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomesAutism: an emerging 'neuroimmune disorder' in search of therapy.A surprising METamorphosis: autism genetics finds a common functional variant.Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances.The Study to Explore Early Development (SEED): a multisite epidemiologic study of autism by the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) network.Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression.A Search for Blood Biomarkers for Autism: Peptoids.Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.Maternal exposure to intimate partner abuse before birth is associated with autism spectrum disorder in offspringDeveloping a Deeper Understanding of Autism: Connecting Knowledge through Literature Mining.Dysautonomia in autism spectrum disorder: case reports of a family with review of the literatureThe autism risk genes MET and PLAUR differentially impact cortical developmentAssociation of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary reportMetabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study.Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
P2860
Q21133642-9A05BF20-C8EB-47E0-8152-060540C2740DQ21260340-E36EA798-D38B-418B-A125-746514B1A3C2Q21560928-5D789B9A-2AAB-4B3D-A470-A72CEE998244Q22252305-3AC513DA-E04E-4CAD-9CFE-BFAB0A89CE93Q24650845-56127BFC-36DF-4183-8936-9BC0871C6200Q24674115-1E6C193F-C5AF-4DC4-9415-CCD9B5C31438Q26748761-559FEFA2-DB1F-45F0-866F-E322F53767F9Q26825821-AB4854F6-C3DC-4B27-836C-A62CE9035819Q28268535-2012A5D8-81EF-4B4D-B2C3-70464DC6E9C6Q28271410-EB8AE06E-D132-480F-A7EF-90CE5EB89E41Q28275427-8C2496FB-4D99-4196-97A2-C2CC31BBBE6EQ28475568-903D49E0-0BEE-494A-842A-DC335F970006Q30477710-EA9CAADB-63B6-4AD9-9686-8900D08F7C1DQ33429117-6267ED87-A98E-47BE-A061-13996B58D9CDQ33800078-6FA60DDA-EDF2-4F08-8080-1FFA3CACEAD8Q33865755-E3F7BAAA-860D-4715-A1E3-A4B8D2C5D537Q34141979-867673B9-89D3-4F33-B9C1-B8652CCA5F7BQ34348399-5F4C21EE-98E3-4A99-ACC1-D02D9F41AF3CQ34422875-686CC8E1-0D24-422E-8125-FA69C5D55918Q34665037-3440244F-1523-41AB-91F7-2C57A17B641FQ34721379-72BA7F9F-2E95-4A98-A74A-EB2688436647Q34818778-D4356377-5501-423F-9EAF-231EC97BF388Q34994653-A00F0CCA-6D64-45C6-B3B4-9FE85421A267Q35130629-C8C928FA-C101-4CFD-8C7A-11B823307939Q35657212-449ADAB4-8091-4B68-9512-6CD4D0F64C22Q35683981-F4BE32A1-9698-4AA3-8A9D-1E1AA605F4C4Q35757725-5F70577E-A58C-4FF9-AEF8-0546F597D762Q35844122-E8FA021B-FEA6-4366-8D54-A2F302EEA09FQ35893489-FE2EED1A-9691-4EF5-A74E-DAA19428CC58Q35994564-C7D735DD-453C-47DE-82CF-9324B74C0E01Q36150334-E9ADCCF5-FEC1-4E1C-98DC-1F103D0E5113Q36161978-5AA0478B-E42E-49FA-B575-95F9CED62E75Q36168635-6DFF2F74-8768-4005-85BD-587FB8030512Q36168998-6E883922-BC8B-433D-B3DD-0CF9C40AA294Q36815851-72962E0F-4355-4905-BB7A-534C87AF85F0Q36892242-804D830C-19EF-4AB4-8CF3-A218D0629327Q37029453-0DCCD4FA-5CE2-4E43-8DC6-0C243E48371EQ37059280-FE4E68A8-5820-48E9-8DD7-471284FB57C8Q37280911-0AE02CDE-204B-408F-A46A-8BA66D6F5D91Q37300512-A29FEC74-1B7D-4609-81E4-6E30BA06B309
P2860
Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dysregulated innate immune res ...... toms and dietary intervention.
@ast
Dysregulated innate immune res ...... toms and dietary intervention.
@en
Dysregulated innate immune res ...... toms and dietary intervention.
@nl
type
label
Dysregulated innate immune res ...... toms and dietary intervention.
@ast
Dysregulated innate immune res ...... toms and dietary intervention.
@en
Dysregulated innate immune res ...... toms and dietary intervention.
@nl
prefLabel
Dysregulated innate immune res ...... toms and dietary intervention.
@ast
Dysregulated innate immune res ...... toms and dietary intervention.
@en
Dysregulated innate immune res ...... toms and dietary intervention.
@nl
P2093
P2860
P356
P1433
P1476
Dysregulated innate immune res ...... toms and dietary intervention.
@en
P2093
Agnes Ruby
Barbie Zimmerman-Bier
Harumi Jyonouchi
P2860
P356
10.1159/000084164
P577
2005-01-01T00:00:00Z